Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder
Crossref DOI link: https://doi.org/10.1007/s11096-016-0281-x
Published Online: 2016-04-06
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Geurts, Marlies M. E.
Stewart, Roy E.
Brouwers, Jacobus R. B. J.
de Graeff, Pieter A.
de Gier, Johan J.
License valid from 2016-04-06